Market News / Story
GeneDx Presents New Evidence Advancing Genomic Newborn Screening at ICoNS 2026
BusinessWire ·
BusinessWire reports: GeneDx ( ), the leader in rare disease diagnosis and improving health through the power of genomic data, today announced new findings to be presented at the International Consortium on Newborn Sequencing (ICoNS), October 7-8 in Boston, demonstrating progress toward making genomic newborn screening (gNBS) a scalable and accessible part of proactive healthcare. As a sequencing and interpretation partner behind leading gNBS programs, including the Genomic…